Antibiotic alternatives for the new millennium

London, London
Wednesday, 05 November 2014

This event will be held at The O2,  a large entertainment district on the Greenwich peninsula in South East London, England.
Antibiotic alternatives for the new millennium
Wednesday, 05 November 2014 09:30 -
Friday, 07 November 2014 17:00

Cineworld: The O2
Peninsula Square
SE10 0DX
United Kingdom

Map and Directions
The inexorable rise in the incidence of antibiotic resistance in bacterial pathogens, coupled with the disappointingly low rate of emergence of new,clinically useful antibiotics, has refocused attention on finding alternatives to antibiotic treatments. This event will discuss the potential utility of phages, probiotics, antimicrobial peptides, herbal medicines and immune modulation for treating human and animal disease. This event has CPD accreditation.

Who Should Attend
From researchers trying to find alternatives to therapies to pharmacists delivering treatments: any one with an interest in antibiotic alternatives would find this event of value.

This event has an open oral and poster session.  
Abstract can be submitted on any subject related to antibiotic alternatives

The deadline for abstract submissions for oral presentation is August 10th 2014
Abstracts for poster presentation only can be submitted up to two weeks before the event. You can download the instructions for authors at

Talks Include:

Novel Host Therapeutic Targets regulating M.tuberculosis infection
Mr Cornelis Korbee, PhD Student, Leiden University Medical Center, The Netherlands

Pro- & Synbiotics - an alternative to antibiotics?
Professor Stig Bengmark, Honorary Visiting Professor, Division of Surgery & Interventional Science, University             College London, UK

HBD3 regulates matrix metalloproteinase production in human myeloid dendritic cells exposed to Porphyromonas gingivalis hemagglutinin B (HagB)
Professor Kim A. Brogden, Director, Dows Institute for Dental Research, 

The University of Iowa, USA

Quorum sensing inhibitors as an alternate to conventional antibiotics Dr. Pragasam Viswanathan, Associate Professor, VIT University, India

Serendipity, bees, honey and wounds
Professor Jonathan Cooke, Royal Hampshire County Hospital, UK

Antibiotic versus maggot therapy in diabetic foot ulcer
Professor Chumpon Wilasrusmee, Department of Surgery, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Thailand

Development of bacteriocins for therapy of infections caused by Gram positive and negative MDR pathogens
Dr Arif Frlek, School of Biomedical & Healthcare Sciences, Plymouth University, Plymouth, UK

Bacteriophages for antistaphylococcal therapies - natural repertoire and limitations of choice
Dr. Malgorzata Lobocka, Institute of Biochemistry and Biopysics of the Polish Academy of Sciences, and Autonomous Department of Microbial Biology, Faculty of Agriculture and Biology, Warsaw University of Life Sciences, Poland

From Host-defense peptides to new antimicrobial agents
Dr Paul R. Hansen, University of Copenhagen, Denmark

Anti-microbial cationic peptides as a strategy for innovation in global health therapeutics for human infectious diseases
Dr Hussin Rothan, Researcher, Faculty of Medicine, University of Malaya, Kuala Lumpur , Malaysia

Antibodies as a limitless source of peptides with innate microbicidal and immunomodulatory activity (ultrabodies)
Professor Luciano Polonelli, Full University Professor, University of Parma, Italy

Octapeptins revisited
Dr Tony Velkov, Monash Institute of Pharmaceutical Sciences, Victoria, Australia

Preclinical development of a novel synthetic antimicrobial peptide for lung infections and sepsis
Dr Alessandro Pini, Dept. of Medical Biotechnology, University of Siena, SetLance srl Toscana Life Sciences, Italy

Enhancing Host Resistance against Lethal Infections
Professor Roger M. Loria, Virginia Commonwealth University Medical Center, Richmond, Virginia, USA

Echinoderms as source of novel antimicrobial peptides to contrast human pathogens

Dr Domenico Schillaci, Lecturer, University of Palermo, Palermo, Italy

Probiotic bacteria against multiresistant pathogens

Professor Iryna SorokulovaAuburn University, Auburn, AL, USA

Antibiotic therapy corroborated by selected immunomodulating beta blockers                             
Dr. Karin Peuschel, CNP, Switzerland

The potential use and delivery of bacteriophages for the treatment of Staphylococcus aureus wound biofilm infections
Diana R. Alves, University of Bath, UK

Clinical Application of Probiotics in Antibiotic Therapy: the Current and Future Use
Dr Thomas A. Tompkins, Research Director, Lallemand Health Solutions Inc, Montreal, Canada

Dr Syma Khalid, Senior lecturer in Computational Chemistry, University of Southampton, Southampton, UK

Keywords:  Infection, Bacteriophage, Resistance,Toxin ,Purification Monolith,Yield ,Scaleable, cGMP, clinical trials, regulation, FDA, EMA, therapeutic use, lung, infection, Campylobacter, phage therapy, poultry, biofilms, Clostridium difficile, genomes, diagnostic, therapeutic, Metagenomics, ecology, microbial functioning,  Genomics, Metabolism, Clostridium difficile, Pseudomonas aeruginosa, gastrointestine, probiotic, herbal, phage nanobiotechnology, antibiotic, antimicrobial peptides, Probiotics, adjunctive therapy, Bacillus probiotic, antagonistic activity, antibiotic-resistant pathogens, Antimicrobial peptides, flaviviruses, alphaviruses, bacteria, antibiotic alternatives, Antimicrobial peptides, antibiotic resistance, staphylococcal biofilms, Probiotics,Immunomodulators,Antiinflammatory, Antiarthritis,Lactobacilli, Androstenes; Steroids; Infection; viral and bacterial :Immune regulation, antibiotics, mult-drug resistance, octatpeptins, polymyxins, Maggot wound therapy, diabetic foot ulcer, chronic wound, wouund healing, antibiotic time, Androstenes; Steroids; Infection; viral and bacterial :Immune regulation, Quorum senser, device associate infection, anti-microbial agents, auto-inducers, Tuberculosis, host, signalling, phagosome, macrophage, Antibodies, peptides, antibiotics, immunomodulators,Innate Immunity, Macrophages, Immunoregulation, Nitric Oxid, Staphylococcus aureus, phage therapy,  antibiotic  resistance, phage-bacteria interactions, Wound healing, Multi-drug resistant bacteria, Surgihoney, Free oxygen radicals, two-component signal transduction, histidine kinase inhibitors, antibiotics, MRSA, WalK, Serendipity, bees, honey and wounds, antibiotics, Gram-negative bacteria, antimrobial peptide, computational


Contact Details

Payment Instructions

  • Payment must be received prior to the meeting

    Credit card
    You can pay during your online registration using your credit card. The information taken will be by secure server. Using this mode of payment you can guarantee that your fee has reached us prior to the conference and you will be listed as registered 

    You can either use your Paypal account or click on the no account link to pay directly by credit or debit card

    If you wish to pay by purchase order or bank transfer, please contact

        Linked in   
An event from European Scientific Conferences - Euroscicon "Specialising in communicating cutting edge technology & methodology in the Life Sciences"

EuroSciCon Ltd. Registered in England and Wales, Company number: 4326921, Registered Office: 47 Falkland Road, High Barnet, EN5 4LQ. 

© 2016
Quick, easy and affordable online event registration and event management software for all event sizes.